Literature DB >> 32244015

Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy.

Grégoire Monseau1, Océane Landon-Cardinal2, Werner Stenzel3, Yoland Schoindre4, Kubéraka Mariampillai5, Stéphane Barete6, Clothilde Martel7, Agathe Masseau8, Alain Meyer9, Benjamin Terrier10, Sarah Guégan11, Laurence Verneuil12, Sylvain Audia13, Cristian Bulai Livideanu14, Eric Hachulla15, Jean-Emmanuel Kahn16, Guillaume Lefevre15, François Maurier17, Guillaume Moulis18, Thomas Papo19, Antoine Dossier19, Vincent Descamps20, Emmanuelle Salort-Campana21, Marie-Aleth Richard22, Emmanuel Bergot23, Laurent Mortier24, Nathalie Costedoat-Chalumeau10, Séverine Genot25, Florian Perez26, Anne-Marie Piette16, Maxime Samson13, Nicolas Schleinitz27, Thierry Zénone28, Marie Lacoste29, Hubert de Boysson1, Serge Madaule30, Aude Rigolet4, Nicolas Champtiaux4, Baptiste Hervier4, Anne-Marie Bouvier31, Valérie Jooste31, Sarah Léonard-Louis32, Thierry Maisonobe32, Achille Aouba1, Olivier Benveniste5, Boris Bienvenu1, Yves Allenbach33.   

Abstract

Entities:  

Year:  2020        PMID： 32244015     DOI： 10.1016/j.jaad.2020.03.058

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis.

Authors:  David F Fiorentino; Livia Casciola-Rosen
Journal:  Clin Rev Allergy Immunol       Date:  2022-05-20       Impact factor: 8.667

Review 2.  Dermatomyositis autoantibodies: how can we maximize utility?

Authors:  Luqman Mushila Hodgkinson; Tiffany Tingshuen Wu; David Franklin Fiorentino
Journal:  Ann Transl Med       Date:  2021-03

3.  Antinuclear Antibody (ANA) and Anti-Mi-2-Alpha Positive Dermatomyositis Hinting a Cancer Diagnosis.

Authors:  Mariana Pacheco; Helena Ferreira; Clara Silva; João Silva; Emanuel Matias; Teresa Antunes; Jorge S Almeida
Journal:  Cureus       Date:  2022-02-02

4.  NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.

Authors:  Corinna Preusse; Pascale Eede; Lucie Heinzeling; Kiara Freitag; Randi Koll; Waltraud Froehlich; Udo Schneider; Yves Allenbach; Olivier Benveniste; Anne Schänzer; Hans-Hilmar Goebel; Werner Stenzel; Josefine Radke
Journal:  Brain Pathol       Date:  2021-05       Impact factor: 6.508

5.  Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.

Authors:  Yuhei Ito; Yoshiki Yamamoto; Yasuo Suzuki; Kentaro Noda; Ayako Nakajima
Journal:  Intern Med       Date:  2021-07-30       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.